Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.08 - $0.55 $1,000 - $6,875
12,500 Added 14.26%
100,142 $8.67 Million
Q2 2023

Aug 11, 2023

SELL
$0.56 - $1.17 $9,722 - $20,312
-17,361 Reduced 16.53%
87,642 $49.1 Million
Q1 2023

May 18, 2023

BUY
$1.02 - $1.39 $107,103 - $145,954
105,003 New
105,003 $120 Million

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Titleist Asset Management, LLC Portfolio

Follow Titleist Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, LLC with notifications on news.